Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
The company has received five final approvals
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Lack of technology transfer stands out as a formidable barrier
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Need to harmonize traditional and modern medicine to combat alarming health problems
Subscribe To Our Newsletter & Stay Updated
